BCI (Brain Computer Interface) Intervention in Autism
Launched by UNIVERSITY OF COIMBRA · May 14, 2015
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Clinical research has demonstrated that ASD children have deficits in the interpretation of others intentions from gaze-direction or other social attention cues (Baron-Cohen, Baldwin, \& Crowson, 1997).
The purpose of the study is to investigate whether a brain computer interface (BCI) using electroencephalographic (EEG) signals can be used to train social cognition skills (in particular interpretation of gaze direction pointing to objects of interest) in ASD patients and whether this improves clinical symptoms.
The intervention comprehends seven BCI sessions spread over four months. The ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Positive diagnostic results for ASD in:
- • Autism Diagnostic Interview-Revised; Autism Diagnostic Observation Schedule; The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
- Exclusion Criteria:
- • Global Intelligence Quotient \< 80
- • Associated medical condition such as epilepsy, neurocutaneous or other genetic syndromes, or other usual comorbidity in ASD samples
About University Of Coimbra
The University of Coimbra, a prestigious institution in Portugal, is dedicated to advancing medical research and innovation through its clinical trial initiatives. With a strong emphasis on collaborative research and interdisciplinary approaches, the university fosters a robust environment for the development of cutting-edge therapies and interventions. Its clinical trials aim to address critical health challenges, leveraging the expertise of its distinguished faculty and state-of-the-art facilities. Committed to ethical standards and patient welfare, the University of Coimbra plays a pivotal role in translating scientific discoveries into tangible health solutions, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Miguel S Castelo-Branco, MD, PhD.
Principal Investigator
IBILI - Institute for Biomedical Imaging in Life Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials